YC LogoYC Logo
Back arrow
back

Y Combinator Funds Illuminant Surgical in S22 Batch

September 30, 2022

Illuminant Surgical has been selected to participate in Y Combinator's S22 Batch. 

For the Summer 2022 batch, YC received 19,000 applications from founders around the world and funded 240. Additionally, only 9% of the batch are healthcare companies. We will present to an invite-only audience of investors at YC's 35th Demo Day.

We are excited to work with our partners at YC to help bring our product to patients!

Illuminant overhead equipmentIlluminant overhead equipment

Illuminant allows you to see everything you need to deliver the highest-quality surgical procedures all in one place, in real time.

Our Technology

Similar Articles

Blog

Illuminant Demos to Mount Sinai Neurosurgery

Illuminant team demonstrates product to Mount Sinai Department of Neurosurgery ahead of clinical study.

Blog

Illuminant Begins First In-Human Study at Mount Sinai Hospital

Illuminant began its first-in-human study at Mount Sinai Health System Hospital in New York City.

Publications

Illuminant Manuscript Accepted to Journal of Medical Systems

Journal of Medical Systems Accepts Illuminant Manuscript for Pricing of Surgical Navigation Technologies

Contact Us

Reach out to us to get a closer look at the future of surgical navigation

founders@illuminant.ai
5855 Green Valley Circle
Culver City, CA
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
© 2025 Illuminant. All rights reserved.
Privacy PolicyTerms of Service

The Illuminant Surgical Navigation System is being designed with the intent to improve surgery. All information on this website represents the design goals of Illuminant Surgical and has not been evaluated by the United States Food and Drug Administration (FDA). The product has not been cleared by the FDA and is not for commercial sale in the United States.